Skip to content
LexBuild

Agency Information Collection Activities: Submission for OMB Review; Comment Request

---
identifier: "/us/fr/2024-17647"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Agency Information Collection Activities: Submission for OMB Review; Comment Request"
title_number: 0
title_name: "Federal Register"
section_number: "2024-17647"
section_name: "Agency Information Collection Activities: Submission for OMB Review; Comment Request"
positive_law: false
currency: "2024-08-08"
last_updated: "2024-08-08"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2024-17647"
document_type: "notice"
publication_date: "2024-08-08"
agencies:
  - "Health and Human Services Department"
  - "Substance Abuse and Mental Health Services Administration"
fr_citation: "89 FR 64942"
fr_volume: 89
---

#  Agency Information Collection Activities: Submission for OMB Review; Comment Request

Periodically, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish a summary of information collection requests under OMB review, in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these documents, call the SAMHSA Reports Clearance Officer on (240) 276-0361.

**Project: Medications for the Treatment of Opioid Use Disorder—42 CFR Part 8 (OMB No. 0930-0206) and Opioid Treatment Programs (OTPs)—Revision**

42 CFR part 8 establishes a certification program managed by SAMHSA's Center for Substance Abuse Treatment (CSAT). The regulation requires that opioid treatment programs (OTPs) be certified. “Certification” is the process by which SAMHSA determines that an OTP is qualified to provide opioid use disorder treatment under the federal opioid use disorder treatment standards established by the Secretary of Health and Human Services. To become certified, an OTP must be accredited by a SAMHSA-approved accreditation body. The regulation also provides standards for such services as individualized treatment planning, increased medical supervision, and assessment of patient outcomes. This submission seeks continued approval of the information collection requirements in the regulation and of the forms used in implementing the regulation.

SAMHSA currently has approval for the *Application for Certification to Use Medications for the Treatment of Opioid Use Disorder in a Treatment Program Under 42 CFR 8.11* (Form SMA-162); the *Application for Approval as Accreditation Body Under 42 CFR 8.3(b)* (Form SMA-163); and the *Exception Request and Record of Justification Under 42 CFR 8.11(h)* (Form SMA-168), which may be used on a voluntary basis by OTP practitioners when there is a patient care situation in which the OTP practitioner must make a treatment decision that falls outside of the standards delineated in the regulation. Form SMA-168 is a simplified, standardized form to facilitate the documentation, request, and approval process for exceptions.

SAMHSA believes that the recordkeeping requirements in the regulation are customary and usual practices within the medical and rehabilitative communities and has not calculated a response burden for them. The recordkeeping requirements set forth in 42 CFR 8.4, 8.11 and 8.12 include maintenance of the following:5-year retention by accreditation bodies of certain records pertaining to accreditation; documentation by an OTP of the following: a patient's medical examination when admitted to treatment, a patient's medical history, a care plan, any prenatal support provided the patient if applicable, the medical rationale for initial starting doses above 50mg, the medical rationale for a patient's dosage schedule, and care decisions made as a result of follow-up medical examinations.

The table that follows summarizes the annual reporting burden associated with the regulation, including burden associated with the forms. There are minor changes to these forms to improve data collection, remove unnecessary questions, and align terms with the final 42 CFR part 8 rule released February 2, 2024.

| Form | Number of | Responses/ | Total | Hours/ | Total |
| --- | --- | --- | --- | --- | --- |
|  |  |  |  |  |  |
| SMA-163 | 54 | 26.055 | 1,407 | 0.28 | 394 |
|  |  |  |  |  |  |
| SMA-162 | 751.33 | 17.976 | 13,506 | 0.08 | 1,081 |
| SMA-168 | 1,302.67 | 17.977 | 23,418 | 0.08 | 1,873 |
| Subtotal | 2,054 | 17.977 | 36,925 | 0.08 | 2,954 |
| Total |  |  | 38,332 |  | 3,348 |

Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to *www.reginfo.gov/public/do/PRAMain* . Find this particular information collection by selecting “Currently under 30-day Review—Open for Public Comments” or by using the search function.

Alicia Broadus,

Public Health Advisor.